That includes ongoing partnerships with national laboratories such as Los Alamos National Laboratory, where we are exploring AI-guided protein and catalyst design, including the ability of AI systems to modify biological structures while preserving or improving key functional properties. Over time, we expect these systems to become increasingly capable partners in discovery—helping scientists move faster from question to evidence, from evidence to insight, and from insight to new treatments for patients.
OpenAI与洛斯阿拉莫斯国家实验室合作AI引导的蛋白与催化剂设计，标志着AI研究从解读文献和实验数据，跃迁到主动分子设计的新阶段。这一转变不仅是工具升级，更是OpenAI向R&D基础设施层战略扩张的意图。通过AI直接参与分子结构设计并保持功能特性，OpenAI正在构建从问题到证据、从证据到洞察、再到治疗方案的完整科研加速闭环，重塑基础研发范式。